Indices indicating early renal microvascular disease in diabetes

Open Biomarkers Journal

Volumn 4, Issue 1, 2011, Pages 18-20

  Futrakul, N ^a   Futrakul, P ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Academy of Science   (Thailand)

Author keywords

Diabetes; FE Mg; Renal hemodynamics; Renal microvascular disease; Vascular homeostasis

Indexed keywords

CREATININE; MAGNESIUM; VASODILATOR AGENT;

ANGIOGENESIS; ARTICLE; CAPILLARY FLOW; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY PLASMA FLOW; KIDNEY TUBULE; MICROALBUMINURIA; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; RENOVASCULAR DISEASE; TREATMENT RESPONSE; URINARY EXCRETION;

EID: 84855510482     PISSN: None     EISSN: 18753183     Source Type: Journal    
DOI: 10.2174/1875318301104010018     Document Type: Article

References (18)

1. Bohle AC, Mackensen-Haen S, Wehrmann M. Significance ofpostglomerular capillaries in the pathogenesis of chronic renal failure. Kid Blood Pres Res 1996; 192: pp 191-5.
2. Kang DH, Kanellis J, Hugo C, et al. Role of the microvascularendothelium in progressive renal disease. J Am Soc Nephro 2002;13: 806-16.
3. Nakagawa T, Kang DH, Ohashi R, et al. Tubulointerstitial disease:role of ischemia and microvascular disease. Curr Opin NephrolHypertens 2003; 12: 233-41.
4. Futrakul N, Yenrudi S, Sensirivatana R, et al. Peritubular capillaryflow determines tubulointerstitial disease in idiopathic nephroticsyndrome. Ren Fail 2000; 22: 329-35.
5. Futrakul N, Futrakul P. Vascular homeostasis and angiogenesisdetermine therapeutic effectiveness in type 2 diabetes. Int J VascMed 2011; 10: 1-7.
6. National Kidney Foundation. K/DOQI clinical practice guidelinesfor chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 2002; 39 (Suppl 2), S1-266.
7. Futrakul P, Yenrudi S, Futrakul N, et al. Tubular function andtubulointerstitial disease. Am J Kidney Dis 1999; 33: 886-91.
8. Futrakul N, Butthep P. Early detection of endothelial injury anddysfunction in conjunction with the correction of hemodynamicmaladjustment can effectively restore renal function in type 2 diabeticnephropathy. Clin Hemorheol Microcirc 2006; 34: 373-81.
9. Futrakul N, Yenrudi S, Futrakul P, et al. Peritubular capillary flowand tubular function in idiopathic nephrotic syndrome. Nephron2000; 85: 181-2.
10. T. Deekajorndech, A biomarker for detecting early tubulointerstitialdisease and ischemia in glomerulonephropathy. Ren Fail 2007;29: 1013-8.
11. Futrakul N, Sridama V, Futrakul P. Microalbuminuria-A biomarkerof renal microvascular disease. Ren Fail 2009; 31: 140-3.
12. Tomos C, Mironidou-Tzouveleki M. Vascular endothelial growthfactor (VEGF) and its role in diabetic nephropathy. EpitheoreseKlinikes Farmakologias kai Farmakokinetikes 2009; 27: 275-82.
13. Cho WC, Yip TT, Chung WS, et al. Differential expression ofproteins in kidney, eye, aorta, and serum of diabetic and nondiabeticrats. J Cell Biochem 2006; 39: 256-68.
14. Sun H, Zheng JM, Chen S, et al. Enhanced expression ofANGPTL2 in the microvascular lesions of diabetic lomerulopathy. Nephron Exp Nephrol 2009; 105: 117-23.
15. Cooper ME, Vranes D, Youssef S, et al. Increased renal expressionof vascular endothelial growth factor (VEGF) and its receptorVEBFR2 in experimental diabetes. Diabetes 1999; 48: 2229-39.
16. Nakagawa T, Kosuge T, Haneda M, et al. Abnormal angiogenesisin diabetic nephropathy. Diabetes 2009; 58: 1471-8.
17. Ritt M, Ott C, Raff U, et al. Renal vascular endothelial function inhypertensive patients with type 2 diabetes mellitus. Am J KidneyDis 2009: 53; 281-9.
18. Futrakul N, Kulapatana O, Futrakul P. et al. Enhanced peritubularcapillary flow and renal function can be accomplished in normoaluminurictype 2 diabetic nephropathy. Ren Fail 2011; 33: 312-5.